GSA CAPITAL PARTNERS LLP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$273
-80.4%
3,785
-81.8%
0.03%
-84.4%
Q4 2022$1,392
-99.8%
20,835
+221.5%
0.17%
+68.0%
Q3 2020$618,000
+11.8%
6,480
+22.2%
0.10%
+60.9%
Q4 2019$553,000
+63.6%
5,302
+55.9%
0.06%
+39.1%
Q3 2019$338,000
-71.7%
3,400
-67.5%
0.05%
-65.7%
Q2 2019$1,193,000
+27.3%
10,447
+40.2%
0.13%
+41.1%
Q1 2019$937,000
-24.4%
7,453
-18.4%
0.10%
-33.6%
Q4 2018$1,239,000
-19.8%
9,133
+62.4%
0.14%
+68.2%
Q3 2018$1,544,000
-0.1%
5,624
-24.6%
0.08%
+10.4%
Q2 2018$1,546,000
-38.0%
7,462
-50.6%
0.08%
-41.7%
Q1 2018$2,494,000
+32.0%
15,101
+9.4%
0.13%
+14.8%
Q4 2017$1,890,000
+93.8%
13,800
+51.6%
0.12%
+85.5%
Q1 2016$975,000
+0.3%
9,105
+1.6%
0.06%
+29.2%
Q4 2015$972,000
-9.9%
8,961
-28.9%
0.05%
-9.4%
Q3 2015$1,079,000
-43.7%
12,600
-33.7%
0.05%
-28.4%
Q2 2015$1,917,000
+189.1%
19,000
+120.9%
0.07%
+184.6%
Q1 2015$663,0008,6000.03%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders